BRIDGEWATER, N.J. and BENGALURU, Karnataka, India, April 15, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon ...

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about what a retinal detachment is, including causes and symptoms.

Dr. Michael Kapusta, MD, FRSCS, Ophthalmologist, talks about Retinal Detachment Treatment - Pneumatic Retinoplexy ...

In this Healio Video Perspective from the COPHy meeting, José García-Arumí, MD, PhD, summarizes a debate session he ...

The two most important factors in the development of rhegmatogenous retinal detachment are retinal breaks and vitreous traction. The two goals of retinal reattachment surgery are to seal all ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today a settlement and license agreement with ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug ...

Recovery for mammalian retinal degeneration is limited by a lack of Müller glia (MG)-mediated regeneration. Here authors show blocking Prox1 accumulation and intercellular transfer from retinal ...

Khanani, M.D., M.A, FASRS, DIAMOND Program Steering Committee Chairperson, Oculis Board of Directors member, Scientific Advisory Board Chair of Retina and Director of ... statement of a fact or ...